ESMO 2024 GU Update

Dive into the latest breakthroughs from ESMO 2024, highlighting the Niagara trial's insights on dervalumab plus chemotherapy for bladder cancer. Discover how the STAMPEDE trial reveals metformin's potential benefits in prostate cancer therapy. Explore the SPLASH trial's promising results for treating metastatic castrate-resistant prostate cancer. Learn about the Sunny Forecast trial's impacts on non-clear cell renal cell carcinoma treatments and the innovative findings of the SunRISe-4 trial in bladder cancer therapies.